• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for

tetano

Editor, Senior Moderator
PLoS One


. 2024 May 31;19(5):e0304477.
doi: 10.1371/journal.pone.0304477. eCollection 2024. SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies

Sen Claudine Henriette Ngomtcho[SUP] 1 2 3 [/SUP], Blaise Mboringong Akenji[SUP] 1 [/SUP], Ketina Hirma Tchio-Nighie[SUP] 4 [/SUP], Joseph Fokam[SUP] 5 [/SUP], Etienne Guenou[SUP] 1 [/SUP], Carolle Nsa'Amang Eyebe[SUP] 6 [/SUP], Yvan Junior Nzegni Kamkoum[SUP] 2 [/SUP], Valdex Derick Ntale Tchoffo[SUP] 2 [/SUP], Collins Buh Nkum[SUP] 4 [/SUP], Hervé Christian Tchoudjin Paho[SUP] 1 [/SUP], Yvette Marie Solange Ebogo[SUP] 1 [/SUP], Aude Nanfak[SUP] 4 [/SUP], Martin Maidadi-Foudi[SUP] 7 [/SUP], Crescence Fouda[SUP] 1 [/SUP], Angyiba Serge Andigema[SUP] 2 [/SUP], Lilian Nsah Bongdze-Em[SUP] 2 [/SUP], Beri Nadin Nfor[SUP] 2 [/SUP], Judith Torimiro[SUP] 5 [/SUP], Anne Cécile Zoung-Kanyi Bissek[SUP] 8 9 [/SUP], Michel Noubom[SUP] 2 [/SUP], Marie Claire Assoumou Okomo[SUP] 1 [/SUP], Jérôme Ateudjieu[SUP] 4 10 [/SUP]



Affiliations
Abstract

Background: Health personnel (HP) are on the frontlines during response to public health emergencies like COVID-19. This risk of exposure suggests the need for safety in responding to any pandemic. Therefore, to ascertain the rate of SARS-CoV-2 infection and immunity, and their determinants amongst HP become relevant.
Methods: A cross sectional health facility-based study was carried-out amongst HP in the Centre Region of Cameroon from 1st February to 30th June 2021. Characteristics and access to preventive tools were collected using face-to-face administered questionnaire. Nasopharyngeal swabs and whole blood were collected for PCR, IgG and IgM testing respectively. STATA version 17 software was used for data analysis. Determinants of COVID-19 infection were explored by estimating crude and adjusted Odd Ratio.
Results: Out of 510 HP reached, 458 were enrolled with mean age of 35 (±10) years. Thirty-four (7.4%) were PCR-positive to SARS-CoV-2 with 73.5% being clinicians versus 9 (26.4%) non-clinicians (p = 0.05). Sero-positivity to SARS-CoV-2 IgG/IgM was 40.2% (184/458), with 84.2% being clinicians versus 29 (15.8%) non-clinicians (p = 0.733). Amongst the 34 HP with PCR-positivity, 16 (47%) had no antibodies, while, 15 (44%) were IgG only. An estimate of HP (43.7%) had at least an evidence of PCR, IgG or IgM contact to COVID-19. Determinants of PCR-positivity was being clinical staff (AOR = 0.29, P = 0.039); and that of IgG/IgM were being non clinical staff (AOR = 0.41, p = 0.018) and regular use of face masks (AOR = 0.44, p = 0.001). HP trained on IPC (24%) were mainly from peripheral level (74.7%, p = 0.002).
Conclusion: Active infections were within the range of pandemic control (<10%). However, around two-fifths of participants have had contact with the virus, indicating that HP remains a population at risk of COVID-19 and other similarly-transmitted epidemic prone diseases, and also an important source of transmission. There is need of vaccine to achieve protectiveness, and optimal response also requires capacity building to improve the health system when challenged by a future pandemic.


 
Back
Top Bottom